• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.

    3/7/25 4:05:37 PM ET
    $BFLY
    Medical Electronics
    Health Care
    Get the next $BFLY alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 6)


    Butterfly Network, Inc.

    (Name of Issuer)


    Class A common stock, par value $0.0001 per share, Class B common stock, par value $0.0001 per share

    (Title of Class of Securities)


    124155102

    (CUSIP Number)


    Jonathan M. Rothberg, Ph.D.
    c/o Butterfly Network, Inc., 1600 District Avenue
    Burlington, MA, 01803
    (781) 557-4800

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    03/05/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    Rothberg Jonathan M.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    8,866,114.00
    8Shared Voting Power

    726,696.00
    9Sole Dispositive Power

    8,866,114.00
    10Shared Dispositive Power

    726,696.00
    11Aggregate amount beneficially owned by each reporting person

    9,592,810.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    4.4 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class A common stock. Rows 7, 9 and 11 consists of (i) 2,641,924 shares of Class A common stock of Butterfly Network, Inc. (f/k/a Longview Acquisition Corp.) (the "Issuer") held by Jonathan M. Rothberg, Ph.D., (ii) stock options to purchase 21,645 shares of Class A common stock of the Issuer which are exercisable within 60 days of March 7, 2025, held by Dr. Jonathan M. Rothberg, (iii) 6,202,545 shares of Class A common stock of the Issuer distributed from 2012 JMR Trust Common, LLC and held by entities owned by trusts created for the benefit of Dr. Jonathan Rothberg's children. Rows 8, 10 and 11 consists of 726,696 shares of Class A common stock of the Issuer held by Dr. Rothberg's spouse. Row 13 is calculated based on 216,496,214 shares of Class A common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    Rothberg Jonathan M.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    26,426,937.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    26,426,937.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    26,426,937.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    100 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Rows 7, 9 and 11 consists of 26,426,937 shares of Class B common stock of the Issuer held by 4C Holdings I, LLC, 4C Holdings II, LLC, 4C Holdings III, LLC, 4C Holdings IV, LLC and 4C Holdings V, LLC. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings I, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    9,716,596.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    9,716,596.00
    11Aggregate amount beneficially owned by each reporting person

    9,716,596.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    36.8 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings II, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,621,701.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,621,701.00
    11Aggregate amount beneficially owned by each reporting person

    2,621,701.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.9 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings III, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,621,701.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,621,701.00
    11Aggregate amount beneficially owned by each reporting person

    2,621,701.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.9 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings IV, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,621,701.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,621,701.00
    11Aggregate amount beneficially owned by each reporting person

    2,621,701.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.9 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    CUSIP No.
    124155102


    1 Name of reporting person

    4C Holdings V, LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    PF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    8,845,238.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    8,845,238.00
    11Aggregate amount beneficially owned by each reporting person

    8,845,238.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    33.5 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    This Reporting Person's table is for Class B common stock. Row 13 is calculated based on 26,426,937 shares of Class B common stock of the Issuer outstanding as of February 13, 2025.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Class A common stock, par value $0.0001 per share, Class B common stock, par value $0.0001 per share
    (b)Name of Issuer:

    Butterfly Network, Inc.
    (c)Address of Issuer's Principal Executive Offices:

    1600 District Avenue, Burlington, MASSACHUSETTS , 01803.
    Item 1 Comment:
    Explanatory Note This Amendment No. 6 to Schedule 13D ("Amendment No. 6") amends and supplements the Schedule 13D filed on February 22, 2021, as amended by Amendment No. 1 filed on March 26, 2021, Amendment No. 2 filed on March 28, 2022, Amendment No. 3 filed on September 16, 2022, Amendment No. 4 filed on September 13, 2023 and Amendment No. 5 filed on August 30, 2024 (as amended, the "Schedule 13D") relating to the Class A common stock, par value $0.0001 per share, and Class B common stock, par value $0.0001 per share, of Butterfly Network, Inc. (f/k/a Longview Acquisition Corp.), a Delaware corporation (the "Issuer"). Information reported in the Schedule 13D remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 6. Capitalized terms used but not defined herein have the meanings ascribed to them in the Schedule 13D.
    Item 4.Purpose of Transaction
     
    Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: In connection with estate planning, entities owned by trusts created for the benefit of Dr. Jonathan Rothberg's children have entered into a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the "Plan"), a copy of which is attached hereto as Exhibit 5. Pursuant to the Plan, sales of up to 6,202,545 shares of Class A common stock may be effected during the plan sales period beginning following the cooling-off period contained in Rule 10b5-1(c) on July 7, 2025 and ending on July 3, 2026 in accordance with the terms and conditions of the Plan. The sale of shares of Class A common stock under the Plan is subject to minimum price parameters included in the Plan, and there is no assurance that any shares of Class A common stock will be sold under the Plan.
    Item 7.Material to be Filed as Exhibits.
     
    Item 7 of the Schedule 13D is hereby amended by adding the following exhibit: Exhibit No. 5 - Rule 10b5-1 Trading Plan

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Rothberg Jonathan M.
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D.
    Date:03/07/2025
     
    Rothberg Jonathan M.
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D.
    Date:03/07/2025
     
    4C Holdings I, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
     
    4C Holdings II, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
     
    4C Holdings III, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
     
    4C Holdings IV, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
     
    4C Holdings V, LLC
     
    Signature:/s/ Jonathan M. Rothberg
    Name/Title:Jonathan M. Rothberg, Ph.D., Manager
    Date:03/07/2025
    Get the next $BFLY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BFLY

    DatePrice TargetRatingAnalyst
    3/17/2025Outperform
    William Blair
    9/10/2024$3.00Buy
    Lake Street
    3/29/2023$2.25Neutral
    UBS
    11/29/2022$4.50Outperform
    Oppenheimer
    10/4/2022$9.50Buy
    B. Riley Securities
    12/17/2021$7.00Neutral
    UBS
    More analyst ratings